Noticias de ANVS_US

Noticias del mercado

Últimas noticias sobre ANVS_US — 127 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ANVS_US ✕ 127 resultados
31/03/2026 ANVS_US — AD HOC NEWS
Annovis Bio Inc Stock: Phase 3 Progress in Alzheimer's and Parkinson's Therapies Drives Investor Foc
31/03/2026 ANVS_US — Yahoo Finance
Annovis Publishes Historical Review of Buntanetap in The Scientist
25/03/2026 ANVS_US — Investing.com
Annovis Bio CFO departs, CEO appointed as acting CFO
25/03/2026 ANVS_US — Stock Titan
CFO departs Annovis Bio (ANVS) as CEO Maria Maccecchini takes acting finance role
25/03/2026 ANVS_US — Bitget
Biopharmaceutical company Annovis Bio Inc announced that its CEO Maria Maccecchini will temporarily serve as CFO until the company finds a permanent replacement.
25/03/2026 ANVS_US — TradingView
Annovis Bio's Mark Guerin departs as CFO; Maria Maccecchini to serve as Acting CFO
25/03/2026 ANVS_US — Bitget
Biopharmaceutical company Annovis Bio Inc announced that its CEO Maria Maccecchini will temporarily serve as CFO until the company finds a permanent replacement.
24/03/2026 ANVS_US — MyChesCo ES ← EN
Annovis informa los resultados de 2025 y avanza las pruebas de Buntanetap
22/03/2026 ANVS_US — Stock Titan ES ← EN
Si invirtió $ 1000 en Annovis Bio Inc (ANVS)
19/03/2026 ANVS_US — The Manila Times ES ← EN
Annovis se asocia con NeuroRPM para implementar tecnología de biomarcadores digitales impulsada por IA en un estudio sobre la enfermedad de Parkinson
19/03/2026 ANVS_US — Stock Titan
Wearables track Parkinson's symptoms in Annovis drug study
19/03/2026 ANVS_US — Yahoo Finance
Annovis Partners with NeuroRPM to Deploy AI-Powered Digital Biomarker Technology in Parkinson's Disease Study
19/03/2026 ANVS_US — Yahoo Finance
NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio's Parkinson's Disease Clinical Trial
19/03/2026 ANVS_US — GlobeNewswire
Annovis Partners with NeuroRPM to Deploy AI-Powered Digital Biomarker Technology in Parkinson's Disease Study
19/03/2026 ANVS_US — GlobeNewswire
Annovis Partners with NeuroRPM to Deploy AI-Powered Digital Biomarker Technology in Parkinson's Disease Study
16/03/2026 ANVS_US — GlobeNewswire
Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results
16/03/2026 ANVS_US — The Manila Times
Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results
16/03/2026 ANVS_US — Quiver Quantitative
Annovis Bio, Inc. Announces Business Updates and Financial Results for Fiscal Year 2025, Highlighting Pivotal Advances in Buntanetap Development for Neurodegenerative Diseases
16/03/2026 ANVS_US — Stock Titan
Alzheimer’s oral drug buntanetap enters pivotal trial, 3‑year PD study
16/03/2026 ANVS_US — Yahoo Finance
Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results

Página 6 de 7

keyboard_arrow_up